Form 8-K BIND Therapeutics, Inc For: May 07

Go back to Form 8-K BIND Therapeutics, Inc For: May 07

BIND Therapeutics (BIND) Tops Q1 EPS by 7c

May 7, 2015 7:12 AM EDT

BIND Therapeutics (NASDAQ: BIND) reported Q1 EPS of ($0.44), $0.07 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $2.67 million.

For earnings history and earnings-related data on BIND Therapeutics (BIND) click here.

... More